Earlier this year, we launched our new and improved Lateral Flow Device product line for allergen detection in foodstuffs and environmental samples. These products quickly detect allergens that must be labeled on packaged food products. The new range was launched with the following products: SENSIStrip Peanut, Almond, Crustaceans and Mustard rapid tests. Our customers were pleased to discover the new devices, as […]
HexagonFab secures £1.9m (USD 2.6m) seed funding to launch the Bolt, an analytical lab instrument to speed discovery and production of next-generation biopharmaceuticals The Bolt provides convenient and affordable access to molecular binding analytics Cambridge/Zurich – University of Cambridge spin-out company HexagonFab today announces a £1.9 million (USD 2.6 million) seed funding round, led by Cambridge […]
BURLINGAME, Calif. — Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has launched its latest product, called the Aura CL. Until now, there has been no effective way to measure subvisible particles in cellular therapeutics. The Aura CL is the next generation in Halo Labs’ popular family of instruments. […]
AMSBIO has launched a comprehensive range of cytosections that offer a verified, reproducible and renewable source of positive / negative controls where the expression of the target biomarker is confirmed for accuracy and specificity by an immunoassay. Researchers, antibody and assay developers as well as Immunohistochemistry (IHC) labs often find it difficult to find a reliable and […]
Aldevron, the world’s leading biomanufacturer of plasmid DNA, mRNA and proteins, is expanding its commercial leadership with the addition of Beth Thompson-Webb as Chief Commercial Officer and Todd Howren as Vice President of Sales. Thompson-Webb will be responsible for leading Aldevron’s worldwide sales and marketing strategy where she will utilize her 30 years of industry […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced a license agreement for use of a proprietary Bio-Techne antibody by Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, for its therapeutic development pipeline. Bio-Techne is a global life sciences company providing innovative tools and […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a partnership with Pure Biologics to accelerate the discovery of immuno-oncology antibody-based drugs. “Twist’s unique technological approaches and abilities allow for the rapid generation of diverse […]
FRANKFURT, Germany — Farmako GmbH, GDP certified pharmaceutical wholesaler with a focus on the cannabinoid therapy, initiates cooperation with STADAPHARM GmbH for the supply of THC-testkits to STADAPHARM. The THC-testkits, which are inhouse-developed and produced by Farmako, will be offered by STADAPHARM as of April 2021 as auxiliary tool for pharmacists to conduct the identity […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will exercise its option to purchase all rights to a G-coupled protein receptor (GPCR) library and its proprietary Twist Antibody Optimization (TAO) software, both developed […]
PROVIDES ACCESS TO PROVEN LUMINEX MULTIPLEXING TECHNOLOGY AND MOLECULAR TESTING SOLUTIONS TO BE USED IN UNIQUE TESTING PANELS, GENERATING CRITICAL MASS IN THE MOLECULAR DIAGNOSTICS SPACE SETS THE GROUND FOR NEW PARTNERSHIPS AND BUSINESS DEVELOPMENT OPPORTUNITIES THROUGH LIFE SCIENCE OFFERINGS BROADENS DIASORIN’S PRESENCE IN THE U.S. ACCELERATES LUMINEX TECHNOLOGY AND SOLUTIONS’ PENETRATION OUTSIDE THE U.S. […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
